EUVIMEDEUVIMED entdecken
Crossref

Role of Sodium Phenylbutyrate and Suramin in the Prevention of Ulcerative Colitis Induced by Dextran Sulfate Sodium

Pelin Arda Pirincci, Cansu Özal Coşkun, Ecem Fatma Karaman, Sibel Özden, Engin Kaptan

Experimed · 12.08.2026 · 16 (2) · 137-147

DOI: 10.26650/experimed.1938986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimed, online erschienen am 12.08.2026. Verfasst von Pelin Arda Pirincci und 4 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Ulcerative colitis is a relapsing inflammatory condition confined to the colonic mucosa in which persistent immune activation is accompanied by oxidative damage and epithelial disruption. This study investigated whether sodium phenylbutyrate (PBA) and suramin could mitigate these pathological changes in a mouse model of experimentally induced colitis.Materials and Methods: Following induction of colitis with dextran sulfate sodium (DSS), the efficacy of PBA and suramin was evaluated by clinical disease activity and histological scoring. Using immunohistochemical and spectrophotometric approaches, changes in proliferative activity, antioxidant enzymes, and oxidative stress indicators were analyzed. Western blot analysis was performed to assess cytokine, cyclooxygenase-2, and active caspase-3 levels together with histone 3 lysine 9 trimethylation modification signal transducer and activator of transcription (STAT)1, STAT3, and sirtuin (SIRT) gene expression were quantified by quantitative reverse transcription-polymerase chain reaction (qRT-PCR).

Results

DSS aggravated oxidative stress and inflammatory responses while suppressing proliferative activity, anti-inflammatory signaling, and antioxidant defense systems in colon tissue. Treatment with PBA or suramin partially reversed these alterations, improving redox balance and inflammatory status and modulating gene expression and histone modifications.

Conclusion

These results suggest that PBA and suramin exert protective effects against DSS-induced colitis through the modulation of apoptosis, inflammation, and oxidative stress, supporting their potential therapeutic value in inflammatory bowel diseases.

Zitieren

APA

Pirincci, P. A., Coşkun, C. Ö., Karaman, E. F., Özden, S., & Kaptan, E. (2026). Role of Sodium Phenylbutyrate and Suramin in the Prevention of Ulcerative Colitis Induced by Dextran Sulfate Sodium. Experimed, 16(2), 137-147. https://doi.org/10.26650/experimed.1938986

Vancouver

Pirincci PA, Coşkun CÖ, Karaman EF, Özden S, Kaptan E. Role of Sodium Phenylbutyrate and Suramin in the Prevention of Ulcerative Colitis Induced by Dextran Sulfate Sodium. Experimed. 2026;16(2):137-147. doi:10.26650/experimed.1938986

BibTeX
@article{Pirincci2026,
  author = {Pirincci, Pelin Arda and Coşkun, Cansu Özal and Karaman, Ecem Fatma and Özden, Sibel and Kaptan, Engin},
  title = {Role of Sodium Phenylbutyrate and Suramin in the Prevention of Ulcerative Colitis Induced by Dextran Sulfate Sodium},
  journal = {Experimed},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {137--147},
  doi = {10.26650/experimed.1938986}
}
Kostenlos starten →